Status:
COMPLETED
Reducing Transition Drug Risk
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
University of Victoria
Icahn School of Medicine at Mount Sinai
Conditions:
Hospitalization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patient transfer between sites of care is regular practice during an episode of care in our current health care system. Yet inter-site transfer is associated with lapses in care quality that adversely...
Detailed Description
This is a 2-phase study in which we will employ mixed quantitative and qualitative methods to conduct an evaluation of the IPT tool while improving our understanding of provider prescribing decisions ...
Eligibility Criteria
Inclusion
- All patients who were admitted to the JJ Peters (Bronx) VA Hospital general medical wards (units 7A and 7B) between 10/05-2/06 and stayed least 24 hours
Exclusion
- Patients who were transferred to one of the study units wards (units 7A and 7B) from another JJ Peters (Bronx) VA Hospital acute care unit (e.g., an intensive care unit), or who stayed in the hospital less than 24 hours
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
612 Patients enrolled
Trial Details
Trial ID
NCT00370916
Start Date
October 1 2005
End Date
September 1 2010
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States, 10468